65 related articles for article (PubMed ID: 2418788)
21. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
[TBL] [Abstract][Full Text] [Related]
22. [Characteristic and effective usage of adriamycin].
Horiuchi K; Akimoto M
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
[TBL] [Abstract][Full Text] [Related]
23. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
[TBL] [Abstract][Full Text] [Related]
24. [Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
Tanji S; Obara W; Sugimura J; Ohmori S; Matsushita Y; Tokunaga H; Konda R; Fujioka T; Murai K; Ishida Y
Hinyokika Kiyo; 2004 Feb; 50(2):77-80. PubMed ID: 15101160
[TBL] [Abstract][Full Text] [Related]
25. The impact of cisplat based chemotherapy on advanced ovarian cancer.
Prasad GR; Dalal AV; Tongaonkar HB; Chatterjee S; Kamat MR
J Postgrad Med; 1995; 41(4):95-8. PubMed ID: 10707728
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy of small cell lung cancer].
Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Ryu S; Sakai N; Yamamoto H; Masuda N; Takifuji N
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):966-72. PubMed ID: 2839116
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of advanced testicular cancer].
Murase T; Takashi M; Sobashima T; Shimoji T; Miyake K; Mitsuya H
Hinyokika Kiyo; 1987 Jan; 33(1):47-50. PubMed ID: 2437779
[TBL] [Abstract][Full Text] [Related]
28. [The current management of testicular cancer].
Kotake T; Miki T
Gan To Kagaku Ryoho; 1988 Feb; 15(2):195-204. PubMed ID: 2449134
[TBL] [Abstract][Full Text] [Related]
29. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
Long HJ; Nelimark RA; Podratz KC; Suman V; Keeney GL; Nikcevich DA; Kugler JW; Rowland KM; Kardinal CG; Wos EJ
Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
[TBL] [Abstract][Full Text] [Related]
30. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
Seguchi T; Sakaguchi H; Kajikawa H; Nishioka T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):600-5. PubMed ID: 2435245
[TBL] [Abstract][Full Text] [Related]
31. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of combination chemotherapy including Platidiam in the treatment of malignant testicular tumors.
Garin AM; Lichinitser MR; Khlebnov AV; Tyulyandin SA
Neoplasma; 1987; 34(1):85-8. PubMed ID: 2436066
[TBL] [Abstract][Full Text] [Related]
33. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies.
Vexler AM; Mou X; Gabizon AA; Gorodetsky R
Int J Cancer; 1995 Mar; 60(5):611-5. PubMed ID: 7532157
[TBL] [Abstract][Full Text] [Related]
34. An assessment of alternated versus syncopated CHOP-PVB.
Goldie JH
Cancer Invest; 1991; 9(6):699-701. PubMed ID: 1721001
[No Abstract] [Full Text] [Related]
35. [Influence of cytotoxic chemotherapy on superoxide production by neutrophils in cancer patients].
Yoshida M; Yanagisawa R; Ishida Y; Kishi H
Kansenshogaku Zasshi; 1993 Jan; 67(1):30-5. PubMed ID: 7680704
[TBL] [Abstract][Full Text] [Related]
36. Current status of chemotherapy of solid tumors.
Vélez-García E; Cabanillas F; Grillo-López A
Bol Asoc Med P R; 1975 Jan; 67(1):7-17. PubMed ID: 1054590
[No Abstract] [Full Text] [Related]
37. [Present status of experimental chemotherapy of tumors].
Schmähl D
Dtsch Med Wochenschr; 1966 Nov; 91(47):2132-5. PubMed ID: 5333844
[No Abstract] [Full Text] [Related]
38. [Current status of combination chemotherapy].
Ogawa M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):171-9. PubMed ID: 2418788
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
40. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]